DGXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	579 272
平均出来高	1.05M
時価総額	14.92B
EPS	$0 ( 2024-04-25 )
次の収益日	( $2.32 ) 2024-07-24
Last Dividend	$0.750 ( 2024-04-05 )
Next Dividend	$0 ( N/A )
P/E	18.09
ATR14	$0.0790 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Gregg Vicky B	Buy	81	Common Stock
2024-04-22	Kuppusamy Karthik	Buy	45	Common Stock
2024-04-22	Plewman Patrick	Buy	69	Common Stock
2024-04-22	Samad Sam	Buy	24	Common Stock
2024-04-01	Ring Timothy M	Buy	311	Phantom Stock Units

INSIDER POWER
70.91
Last 98 transactions
Buy: 293 398 \| Sell: 50 988

ボリューム相関

長: -0.35 (neutral)

短: -0.80 (moderate negative)

Signal:(42.582) Neutral

Quest Diagnostics Inc 相関

10 最も正の相関
LLY	0.865
PCK	0.863
PFE	0.858
JNJ	0.856
MOH	0.848
CHAD	0.846
XLV	0.841
CLII	0.839
ADM	0.837
EVTL	0.835

10 最も負の相関
YSAC	-0.949
MTW	-0.895
MNSO	-0.887
BH	-0.878
STLA	-0.877
STN	-0.874
RDW	-0.871
NOA	-0.867
NGL-PC	-0.862
NGL-PB	-0.859

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Quest Diagnostics Inc 相関 - 通貨/商品

0.09
( neutral )

-0.31
( neutral )

0.00
( neutral )

-0.52
( weak negative )

0.13
( neutral )

0.56
( weak )

Quest Diagnostics Inc 財務諸表

Annual	2023
収益:	$9.25B
総利益:	$2.96B (32.00 %)
EPS:	$7.59

FY	2023
収益:	$9.25B
総利益:	$2.96B (32.00 %)
EPS:	$7.59

FY	2022
収益:	$9.88B
総利益:	$3.43B (34.74 %)
EPS:	$8.12

FY	2021
収益:	$10.79B
総利益:	$4.21B (39.02 %)
EPS:	$16.91

Financial Reports:

No articles found.

Quest Diagnostics Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.660 (N/A)	$0.660 (N/A)	$0.660 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)

Quest Diagnostics Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.66 - Increase likely (53.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0750	2004-01-06
Last Dividend	$0.750	2024-04-05
Next Dividend	$0	N/A
Payout Date	2024-04-22
Next Payout Date	N/A
# dividends	82	--
Total Paid Out	$26.61	--
Avg. Dividend % Per Year	1.55%	--
Score	5.89	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.66
Div. Directional Score	9.84	--

Next Divdend (Est)
(2024-07-10)

$0.762 Estimate 73.83 %

Dividend Stability

0.98 Excellent

Dividend Score

5.89

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2004	$0.300	0.83%
2005	$0.345	0.73%
2006	$0.390	0.76%
2007	$0.400	0.78%
2008	$0.400	0.77%
2009	$0.400	0.76%
2010	$0.400	0.65%
2011	$0.400	0.73%
2012	$0.680	1.18%
2013	$1.200	2.05%
2014	$1.290	2.44%
2015	$1.470	2.13%
2016	$1.580	2.23%
2017	$1.800	1.95%
2018	$1.950	1.97%
2019	$2.12	2.58%
2020	$2.21	2.09%
2021	$2.42	2.00%
2022	$2.60	1.58%
2023	$2.79	1.79%
2024	$1.460	1.04%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0911	1.500	8.18	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0606	1.200	7.98	9.57	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.377	-1.000	6.23	-6.23	[0 - 1]
currentRatioTTM	0.970	0.800	-0.152	-0.122	[1 - 3]
quickRatioTTM	0.782	0.800	-0.109	-0.0868	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0.349	-1.500	4.19	-6.29	[0 - 0.6]
interestCoverageTTM	7.95	1.000	8.17	8.17	[3 - 30]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.53	2.00	5.73	10.00	[0 - 20]
debtEquityRatioTTM	0.756	-1.500	6.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.327	1.000	7.88	7.88	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.274	1.000	9.59	9.59	[0.2 - 2]
assetTurnoverTTM	0.666	0.800	8.90	7.12	[0.5 - 2]
Total Score				12.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.62	1.000	8.32	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.53	2.00	7.16	10.00	[0 - 30]
dividendYielPercentageTTM	2.15	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
payoutRatioTTM	0.377	1.500	6.23	-6.23	[0 - 1]
pegRatioTTM	0.619	1.500	9.21	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.143	1.000	8.91	0	[0.1 - 0.5]
Total Score				7.66

Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.